Applied DNA Sciences Files 8-K

Ticker: BNBX · Form: 8-K · Filed: Apr 8, 2025 · CIK: 744452

Sentiment: neutral

Topics: 8-K, filing, disclosure

Related Tickers: APDN

TL;DR

APDN filed an 8-K on 4/8/25 for events on 4/7/25.

AI Summary

Applied DNA Sciences, Inc. filed an 8-K on April 8, 2025, reporting other events and financial statements and exhibits. The filing date indicates the report was submitted on April 8, 2025, with the earliest event reported on April 7, 2025. The company is incorporated in Delaware and headquartered in Stony Brook, New York.

Why It Matters

This 8-K filing indicates a routine update or disclosure from Applied DNA Sciences, Inc. to the SEC, which may contain important information for investors regarding the company's operations or financial status.

Risk Assessment

Risk Level: low — This filing appears to be a standard 8-K for other events and financial statements, not indicating any immediate significant financial distress or major corporate changes.

Key Players & Entities

FAQ

What specific 'Other Events' are being reported in this 8-K filing?

The provided text does not detail the specific 'Other Events' reported, only that this item is included in the filing.

What financial statements and exhibits are included with this 8-K?

The filing indicates that 'Financial Statements and Exhibits' are included, but the specific contents are not detailed in the provided text.

When was the earliest event reported in this filing?

The earliest event reported in this filing occurred on April 7, 2025.

What is the principal executive office address for Applied DNA Sciences, Inc.?

The principal executive offices are located at 50 Health Sciences Drive, Stony Brook, New York 11790.

What is the SEC file number for Applied DNA Sciences, Inc.?

The SEC file number for Applied DNA Sciences, Inc. is 001-36745.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 8, 2025 regarding APPLIED DNA SCIENCES INC (BNBX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing